CollPlant Biotechnologies (CLGN) Current Leases (2019 - 2025)
CollPlant Biotechnologies (CLGN) reported Current Leases of $814000.0 for Q4 2025, up 0.99% on a YoY basis from $806000.0 in Q4 2024, and up 0.99% quarter-over-quarter from $806000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Current Leases (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Current Leases for 7 years, with the latest figure at $814000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 0.99% year-over-year to $814000.0; the trailing twelve-month figure through Dec 2025 stood at $814000.0 (up 0.99% YoY), and the FY2025 full-year result was $814000.0, up 0.99% from the prior year.
- Current Leases for Q4 2025 stood at $814000.0, up from $806000.0 in the prior quarter.
- The five-year high for Current Leases was $814000.0 in Q4 2025, with the low at $519000.0 in Q4 2021.
- Historically, Current Leases has averaged $658400.0 across 5 years, with a median of $624000.0 in 2023.
- Annual changes were most pronounced in 2024 — Current Leases advanced 29.17% — and 2025, when it increased 0.99%.
- CollPlant Biotechnologies' Current Leases stood at $519000.0 in 2021, then increased by 1.93% to $529000.0 in 2022, then increased by 17.96% to $624000.0 in 2023, then increased by 29.17% to $806000.0 in 2024, then increased by 0.99% to $814000.0 in 2025.
- The last three Current Leases figures came in at $814000.0 (Q4 2025), $806000.0 (Q4 2024), and $624000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 814,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Dec 31, 2023 | 624,000.00 |
| Dec 31, 2022 | 529,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Dec 31, 2020 | 440,000.00 |
| Dec 31, 2019 | 455,000.00 |